cardiovascular stent News
-
Arterius Appoints Stever Parker as new Chief Executive Officer
Arterius Limited, a Leeds-based, UK company developing innovative medical devices with a focus on next generation bioresorbable coronary and peripheral stents, has announced that it has appointed Steve Parker as Chief Executive Officer. In the role Steve will lead the next phase of developing and scaling the business as it moves closer to commercialization of it’s suite of innovative and ...
-
Biomedical Catalyst Grant Award to Arterius Limited
Following the successful completion of the R&D project in 30th September 2016 (supported by a Smart award from the Innovate UK (TSB), Arterius has recently been awarded further funding from the Biomedical Catalyst-Early Stage programme to conduct the In-vitro and In-vivo GLP Evaluation of the Novel Bioresorbable Coronary Scaffolds; ArterioSorb. ArterioSorb is an innovative medical implant ...
-
Oncomfort and Vygon sign international partnership for commercialization of Sedakit™, the Digital Sedation™ Virtual Reality solution
Oncomfort, the Belgian inventor of Digital SedationTM - a new method for relieving patients’ pain and anxiety without medication –, and Vygon, global group specializing in single-use medical devices, today announce their commercial partnership in six European countries. The strong synergy between Vygon's specialization and Oncomfort's fields of application will enable greater ...
By Oncomfort
-
Galway’s Shortcut to Global Success with its Med-Tech Startups
The city’s med tech cluster has been the springboard for a start-up which, armed with almost €30m in funding, is on the cusp of a global breakthrough. ARTICLE FROM IRISH INDEPENDENT printed 16.04.16 Pictured in the Veryan Medical R&D Centre, Galway were (from left) Chas Taylor (Chief Executive Officer) and Paul Gilson (Chief Scientific Officer). Photo: Yann Studios. ...
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you